Headlines about Perrigo (NYSE:PRGO) have trended very positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by monitoring more than 6,000 blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Perrigo earned a media sentiment score of 3.33 on their scale. InfoTrie also assigned press coverage about the company an news buzz score of 10 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock’s share price in the near future.
Here are some of the headlines that may have impacted Perrigo’s ranking:
- Perrigo Company plc (PRGO) Under Investor Scrutiny as Price Index Touches 0.870995 – Hartsburg News (hartsburgnews.com)
- $1.02 Earnings Per Share Expected for Perrigo Company PLC (PRGO) This Quarter (americanbankingnews.com)
- Perrigo (PRGO) Receives Daily Media Sentiment Rating of 3.33 (americanbankingnews.com)
- Perrigo (PRGO) Reports Patent Litigation Settlement For Generic Version of Sernivo Spray, 0.05% (streetinsider.com)
- Perrigo settles Sernivo patent dispute with Promius (seekingalpha.com)
A number of research firms have recently issued reports on PRGO. Jefferies Financial Group restated a “hold” rating and issued a $73.00 target price on shares of Perrigo in a report on Friday, August 10th. Wells Fargo & Co reduced their target price on Perrigo from $84.00 to $77.00 and set a “market perform” rating for the company in a report on Tuesday, August 21st. JPMorgan Chase & Co. reduced their target price on Perrigo from $83.00 to $75.00 and set a “neutral” rating for the company in a report on Friday, August 10th. ValuEngine lowered Perrigo from a “sell” rating to a “strong sell” rating in a report on Thursday, November 8th. Finally, Stifel Nicolaus reduced their target price on Perrigo from $92.00 to $87.00 and set a “hold” rating for the company in a report on Friday, August 10th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and three have issued a buy rating to the company. Perrigo presently has a consensus rating of “Hold” and a consensus target price of $82.73.
Perrigo (NYSE:PRGO) last announced its quarterly earnings data on Thursday, November 8th. The company reported $1.09 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.04. Perrigo had a return on equity of 11.32% and a net margin of 2.54%. The business had revenue of $1.13 billion during the quarter, compared to analyst estimates of $1.17 billion. During the same period last year, the company earned $1.39 earnings per share. Perrigo’s quarterly revenue was down 8.0% compared to the same quarter last year. Analysts anticipate that Perrigo will post 4.55 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 18th. Investors of record on Friday, November 30th will be issued a dividend of $0.19 per share. The ex-dividend date of this dividend is Thursday, November 29th. This represents a $0.76 annualized dividend and a dividend yield of 1.22%. Perrigo’s dividend payout ratio is 15.42%.
In other news, CEO Murray S. Kessler acquired 15,683 shares of the business’s stock in a transaction that occurred on Friday, November 9th. The stock was acquired at an average cost of $63.79 per share, for a total transaction of $1,000,418.57. Following the completion of the acquisition, the chief executive officer now owns 13,416 shares in the company, valued at $855,806.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Geoffrey M. Parker acquired 3,000 shares of the business’s stock in a transaction that occurred on Monday, November 12th. The shares were purchased at an average price of $65.35 per share, with a total value of $196,050.00. Following the completion of the acquisition, the director now owns 3,229 shares of the company’s stock, valued at approximately $211,015.15. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 25,783 shares of company stock valued at $1,646,976. 6.90% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION NOTICE: This report was published by Community Financial News and is the sole property of of Community Financial News. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright legislation. The legal version of this report can be read at https://www.com-unik.info/2018/12/03/very-positive-news-coverage-extremely-likely-to-impact-perrigo-prgo-share-price.html.
Perrigo Company Profile
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Recommended Story: Average Daily Trade Volume – ADTV
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.